Erschienen in:
01.05.2005 | Letter to the Editors
Reply concerning “Clinical evaluation of in vitro chemosensitivity testing: the example of uveal melanoma” by Terheyden et al. (2004)
verfasst von:
P. Terheyden, E.-B. Bröcker, J. C. Becker
Erschienen in:
Journal of Cancer Research and Clinical Oncology
|
Ausgabe 5/2005
Einloggen, um Zugang zu erhalten
Excerpt
We are very grateful for the critical and valuable discussion of our paper by Ian Cree and colleagues, even if their letter partially lacks the appropriate style of scientific discussions. Cree et al. mainly judge our trial from the laboratory point of view, which is justified in some aspects, but does not necessarily reflect the clinical situation. It is actually surprising that Cree and colleagues became upset when we tested their suggestion that “treosulfan and gemcitabine might be more active than other drugs” and observed rather discouraging clinical efficacy. …